CJC-1295 Ipamorelin research peptide is a dual research formulation combining CJC-1295 (No DAC) with Ipamorelin. These compounds have been studied in laboratory settings for their interactions with pathways associated with growth hormone signaling and pituitary activity.
CJC-1295 (No DAC) is a growth hormone-releasing hormone (GHRH) analog investigated for its interaction with GHRH receptors and related endocrine signaling. Ipamorelin is a growth hormone secretagogue studied for its interaction with the ghrelin receptor and its role in growth hormone-related signaling.
In laboratory and preclinical research, the combination has been investigated to better understand receptor-specific signaling, pituitary responses, endocrine feedback, and growth hormone-related biological pathways. Findings from laboratory and preclinical research should not be interpreted as evidence of safety or effectiveness in humans.
Revive Peptidez provides CJC-1295 + Ipamorelin research peptide for laboratory research and educational purposes.
Explore additional laboratory research products available from Revive Peptidez in our complete research peptide collection.
Research Use Only
This product is intended strictly for laboratory research purposes. It is not intended for human consumption and is not intended to diagnose, treat, cure, or prevent any disease.
